Febuxostat hemihydrate

Febuxostat hemihydrate is a crystalline form of febuxostat, a non-purine selective inhibitor of xanthine oxidase used to treat hyperuricemia in patients with gout. It is grouped under the following drug class(es): Gout agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Febuxostat hydrate. Its PubChem CID is 56963122.

CAS No 442664-09-7
Molecular Formula C32H34N4O7S2
Molecular Weight 650.8 g/mol
Synonyms bis(2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid);hydrate

Frequently Asked Questions